...
首页> 外文期刊>Current Pharmaceutical Biotechnology >Preparation of Chitosan/Alginate-ellagic Acid Sustained-release Micro- spheres and their Inhibition of Preadipocyte Adipogenic Differentiation
【24h】

Preparation of Chitosan/Alginate-ellagic Acid Sustained-release Micro- spheres and their Inhibition of Preadipocyte Adipogenic Differentiation

机译:壳聚糖/海藻酸鞣花酸缓释微球的制备及其对脂肪细胞成脂分化的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: In this study, chitosan/alginate-ellagic acid sustained-release microspheres were prepared, and the effect of sustained-release microspheres on preadipocyte adipogenic differentiation was analyzed.Methods: Chitosan/alginate-ellagic acid microspheres were prepared and identified by scanning electron microscopy (SEM) and infrared spectroscopy (IR). The drug release rates were measured at pH 6.8, 7.0, 7.2, 7.4 to determine sustained release of ellagic acid from microspheres. The effects of 0.1, 1, 10 mg/L chitosan/alginate-ellagic acid microsphere on 3T3-F442A preadipocyte proliferation were determined by Methyl thiazolyl tetrazolium assay (MU), and cell morphology was checked by hematoxylin/eosin staining (HE staining). The effect of chitosan/alginate-ellagic acid microspheres on preadipocyte adipogenic differentiation was also determined by Oil red O staining, and lipogenesis was measured by isopropanol extraction. The molecular mechanism was investigated by detecting the mRNA expression of CCAAT/enhancer binding protein alpha (C/EBP alpha) and peroxisome proliferatorsactivated receptor gamma (PPAR gamma).Results: Chitosan/alginate-ellagic acid sustained-release microspheres were successfully prepared, and the inhibition of proliferation and adipogenic differentiation of preadipocytes was found to be dosedependent. The mechanism of differentiation inhibition was found to be closely related to the expression of transcription factor C/EBPa and PPAR gamma.Conclusion: Chitosan/alginate can be used as a good material to prepare ellagic acid sustained-release microspheres, and these microspheres can be used for treating the obesity.
机译:目的:制备壳聚糖/海藻酸钠-鞣花酸缓释微球,并分析缓释微球对前脂肪细胞成脂分化的影响。显微镜(SEM)和红外光谱(IR)。在pH 6.8、7.0、7.2、7.4处测量药物释放速率,以确定鞣花酸从微球的持续释放。用甲基噻唑基四唑鎓测定法(MU)测定0.1、1、10 mg / L的壳聚糖/藻酸-鞣花酸微球对3T3-F442A前脂肪细胞增殖的影响,并用苏木精/曙红染色(HE染色)检查细胞形态。还通过油红O染色确定了壳聚糖/藻酸盐-鞣花酸微球对脂肪细胞前脂肪形成的影响,并通过异丙醇萃取来测量脂肪形成。通过检测CCAAT /增强子结合蛋白α(C /EBPα)和过氧化物酶体增殖物激活受体γ(PPARγ)的mRNA表达来研究其分子机制。结果:成功制备了壳聚糖/海藻酸-鞣花酸缓释微球,发现前脂肪细胞的增殖和脂肪形成分化的抑制是剂量依赖性的。结论:壳聚糖/藻酸盐可以作为制备鞣花酸缓释微球的良好材料,壳聚糖/海藻酸盐可以作为制备这种活性物质的良好物质,其分化抑制机制与转录因子C / EBPa和PPARγ的表达密切相关。用于治疗肥胖症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号